Evidence Hub

Clinical Feasibility Study, Implantable Tibial Nerve Stimulator (ITNS)

ClinicalTrials.gov · COMPLETED, 2021

10 participants

Abstract

Study objectives: To report feasibility data for safety and effectiveness of the study device.

Study device: Nine Continents Medical implantable tibial nerve stimulator (ITNS) model 9C-680 with programmer model 9C-580.

Intended use: The study device is intended for treatment of the symptoms of overactive bladder (OAB), including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments.

Type of design: Single-arm longitudinal design.

Study sites: Single site, in the United States.

Study duration: One year total, comprising six months for enrolling and implanting 10 subjects, and 26 weeks for follow-up.

Conditions: Overactive Bladder.

Primary outcome: Percent Change of Urinary Incontinence Frequency From Baseline to 13 Weeks; Percent Change of Excess Voiding Frequency During Waking Hours From Baseline to 13 Weeks; Percent Change of Frequency of Voids Awakening From Sleep From Baseline to 13 Weeks; Percent Change of Frequency of Voids With Urgency From Baseline to 13 Weeks.

Enrollment: 10 participants.

How strong is the evidence?

Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 10 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free